292 related articles for article (PubMed ID: 12371635)
1. Successful treatment of familial Mediterranean fever attacks with thalidomide in a colchicine resistant patient.
Seyahi E; Ozdogan H; Masatlioglu S; Yazici H
Clin Exp Rheumatol; 2002; 20(4 Suppl 26):S43-4. PubMed ID: 12371635
[TBL] [Abstract][Full Text] [Related]
2. Treatment options in colchicine resistant familial Mediterranean fever patients: thalidomide and etanercept as adjunctive agents.
Seyahi E; Ozdogan H; Celik S; Ugurlu S; Yazici H
Clin Exp Rheumatol; 2006; 24(5 Suppl 42):S99-103. PubMed ID: 17067437
[TBL] [Abstract][Full Text] [Related]
3. The efficacy of anakinra in an adolescent with colchicine-resistant familial Mediterranean fever.
Calligaris L; Marchetti F; Tommasini A; Ventura A
Eur J Pediatr; 2008 Jun; 167(6):695-6. PubMed ID: 17588171
[TBL] [Abstract][Full Text] [Related]
4. The efficacy of continuous interferon alpha administration as an adjunctive agent to colchicine-resistant familial Mediterranean fever patients.
Calguneri M; Apras S; Ozbalkan Z; Ozturk MA; Ertenli I; Kiraz S
Clin Exp Rheumatol; 2004; 22(4 Suppl 34):S41-4. PubMed ID: 15515783
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic approach to patients with familial Mediterranean fever-related amyloidosis resistant to colchicine.
Korkmaz C
Clin Exp Rheumatol; 2012; 30(3 Suppl 72):S104-7. PubMed ID: 23010471
[TBL] [Abstract][Full Text] [Related]
6. Biological agents in familial Mediterranean fever focusing on colchicine resistance and amyloidosis.
Sozeri B; Kasapcopur O
Curr Med Chem; 2015; 22(16):1986-91. PubMed ID: 25760087
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the efficacy and safety of tocilizumab for colchicine-resistant or colchicine-intolerant familial Mediterranean fever: study protocol for an investigator-initiated, multicenter, randomized, double-blind, placebo-controlled trial.
Koga T; Sato S; Miyamoto J; Hagimori N; Kawazoe Y; Arinaga K; Fukushima C; Yamamoto H; Kawakami A
Trials; 2018 Dec; 19(1):715. PubMed ID: 30594222
[TBL] [Abstract][Full Text] [Related]
8. Biologic therapy in familial Mediterranean fever.
Koga T; Migita K; Kawakami A
Mod Rheumatol; 2016 Sep; 26(5):637-41. PubMed ID: 26939747
[TBL] [Abstract][Full Text] [Related]
9. [INTERLEUKIN 1 INHIBITORS--A NEW HORIZON IN THE TREATMENT OF FAMILIAL MEDITERRANEAN FEVER].
Shouval R; Livneh A; Ben-Zvi I
Harefuah; 2015 Nov; 154(11):716-9, 741. PubMed ID: 26821505
[TBL] [Abstract][Full Text] [Related]
10. Update on the management of colchicine resistant Familial Mediterranean Fever (FMF).
El Hasbani G; Jawad A; Uthman I
Orphanet J Rare Dis; 2019 Oct; 14(1):224. PubMed ID: 31615541
[TBL] [Abstract][Full Text] [Related]
11. Familial Mediterranean fever successfully treated with etanercept.
Mor A; Pillinger MH; Kishimoto M; Abeles AM; Livneh A
J Clin Rheumatol; 2007 Feb; 13(1):38-40. PubMed ID: 17278949
[TBL] [Abstract][Full Text] [Related]
12. Treatment of colchicine-resistant Familial Mediterranean fever in children and adolescents.
Eroglu FK; Beşbaş N; Topaloglu R; Ozen S
Rheumatol Int; 2015 Oct; 35(10):1733-7. PubMed ID: 26001859
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic approach to familial Mediterranean fever: a review update.
Ozturk MA; Kanbay M; Kasapoglu B; Onat AM; Guz G; Furst DE; Ben-Chetrit E
Clin Exp Rheumatol; 2011; 29(4 Suppl 67):S77-86. PubMed ID: 21968242
[TBL] [Abstract][Full Text] [Related]
14. Clinical improvement with infliximab in a child with amyloidosis secondary to familial Mediterranean fever.
Yüksel S; Yalçinkaya F; Acar B; Ozçakar ZB; Oztürk B; Ekim M
Rheumatology (Oxford); 2006 Oct; 45(10):1307-8. PubMed ID: 16880190
[No Abstract] [Full Text] [Related]
15. Familial mediterranean fever: a fascinating model of inherited autoinflammatory disorder.
Portincasa P; Scaccianoce G; Palasciano G
Eur J Clin Invest; 2013 Dec; 43(12):1314-27. PubMed ID: 24117178
[TBL] [Abstract][Full Text] [Related]
16. Non-response to colchicine in familial Mediterranean fever should be identified accurately.
Melikoglu MA; Senel K
Int J Rheum Dis; 2017 Dec; 20(12):2118-2121. PubMed ID: 24702830
[TBL] [Abstract][Full Text] [Related]
17. Association between familial mediterranean fever and retroperitoneal fibrosis: retroperitoneal fibrosis regression after colchicine therapy.
De Socio G; Cerquaglia C; Curigliano V; Fonnesu C; Giovinale M; Verrecchia E; Marino GM; Natale L; Gasbarrini GB; Manna R
Int J Immunopathol Pharmacol; 2009; 22(2):521-4. PubMed ID: 19505404
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of intermittent colchicine therapy in familial Mediterranean fever.
Wright DG; Wolff SM; Fauci AS; Alling DW
Ann Intern Med; 1977 Feb; 86(2):162-5. PubMed ID: 319724
[TBL] [Abstract][Full Text] [Related]
19. Successful treatment of familial Mediterranean fever with Anakinra and outcome after renal transplantation.
Moser C; Pohl G; Haslinger I; Knapp S; Rowczenio D; Russel T; Lachmann HJ; Lang U; Kovarik J
Nephrol Dial Transplant; 2009 Feb; 24(2):676-8. PubMed ID: 19033248
[TBL] [Abstract][Full Text] [Related]
20. Colchicine prophylaxis in familial Mediterranean fever: reappraisal after 15 years.
Ben-Chetrit E; Levy M
Semin Arthritis Rheum; 1991 Feb; 20(4):241-6. PubMed ID: 2042056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
